Holen Sie sich die Stockscreener-App
1.02
3.03%
0.03
Handel nachbörslich:
1.00
-0.02
-1.96%
Immunic Inc Aktie (IMUX) Neueste Nachrichten
HB Wealth Management LLC Acquires New Shares in Immunic, Inc. (NASDAQ:IMUX) - Defense World
IMUX Stock Touches 52-Week Low at $0.97 Amid Market Challenges - MSN
Immunic, Inc. (NASDAQ:IMUX) Sees Large Increase in Short Interest - MarketBeat
Jane Street Group LLC Grows Position in Immunic, Inc. (NASDAQ:IMUX) - Defense World
Analysts Set Immunic, Inc. (NASDAQ:IMUX) PT at $12.67 - Defense World
Immunic, Inc. (NASDAQ:IMUX) Receives $12.67 Average PT from Brokerages - MarketBeat
Immunic eyes transformative year ahead for MS therapy vidofludimus calciumICYMI - Proactive Investors Australia
Immunic ‘on track’ with MS clinical trials testing vidofludimus calcium - Multiple Sclerosis News Today
Immunic (NASDAQ:IMUX) Earns “Buy” Rating from D. Boral Capital - Defense World
Immunic COO Jason Tardio discusses key 2024 highlights, 2025 milestones - Proactive Investors Australia
Immunic eyes key data readout from multiple sclerosis trial in 2025 - Proactive Investors Australia
D. Boral Capital Reaffirms "Buy" Rating for Immunic (NASDAQ:IMUX) - MarketBeat
Immunic Highlights 2024 Accomplishments and Upcoming Milestones - PR Newswire
State Street Corp Boosts Holdings in Immunic, Inc. (NASDAQ:IMUX) - Defense World
Brokerages Set Immunic, Inc. (NASDAQ:IMUX) PT at $11.80 - Defense World
Immunic CEO Daniel Vitt secures new employment terms - Investing.com
Immunic CEO Daniel Vitt secures new employment terms By Investing.com - Investing.com South Africa
Immunic, Inc. (NASDAQ:IMUX) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Immunic, Inc. (NASDAQ:IMUX) Short Interest Update - Defense World
Immunic, Inc. (NASDAQ:IMUX) Short Interest Up 10.3% in November - MarketBeat
Immunic CEO Dr Daniel Vitt on successful 2024, with more to come in the year ahead - Proactive Investors Australia
Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update - The Eastern Progress Online
Janus Henderson Group PLC Sells 1,974,566 Shares of Immunic, Inc. (NASDAQ:IMUX) - MarketBeat
Immunic CSO discusses breaking the IBD stigma to mark Crohn's and Colitis Awareness Week - Proactive Investors UK
Broad Benefits Of Immunic MS Drug Could Transform Treatment - News & Insights
B. Riley Has Bearish Forecast for Immunic FY2024 Earnings - Defense World
B. Riley Estimates Immunic's FY2024 Earnings (NASDAQ:IMUX) - MarketBeat
FY2024 Earnings Estimate for Immunic Issued By HC Wainwright - Defense World
IMUXImmunic, Inc. Latest Stock News & Market Updates - StockTitan
HC Wainwright Begins Coverage on Immunic (NASDAQ:IMUX) - Defense World
HC Wainwright Estimates Immunic’s Q4 Earnings (NASDAQ:IMUX) - Defense World
Immunic, Inc. to Participate in Investor Conference in December - The Malaysian Reserve
Immunic to present at Piper Sandler 36th Annual Healthcare Conference - Proactive Investors USA
What is HC Wainwright's Estimate for Immunic Q4 Earnings? - MarketBeat
H.C. Wainwright bullish on Immunic stock—Phase 3 MS drug de-risks outlook - Investing.com Nigeria
H.C. Wainwright bullish on Immunic stock—Phase 3 MS drug de-risks outlook By Investing.com - Investing.com South Africa
Immunic initiated with a Buy at H.C. Wainwright - TipRanks
Immunic, Inc. (NASDAQ:IMUX) Receives $12.25 Average Price Target from Analysts - MarketBeat
Immunic, Inc. (NASDAQ:IMUX) Short Interest Up 29.7% in October - Defense World
5.49%
0.79%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):